Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 4Lymphoma, Non-Hodgkin 4Lymphoma 4Lymphoma, Large-Cell, Anaplastic 2Hematologic Neoplasms 2Solid Tumor 1Sarcoma, Synovial 1Sarcoma 1Rhabdoid Tumor 1Recurrence 1Multiple Myeloma 1Mesothelioma 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Hodgkin Disease 1Hematologic Diseases 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumors 1Advanced Solid Neoplasm 1

Interventions

pevonedistat 2Paclitaxel 2Docetaxel 2Carboplatin 2Rifampin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Advanced Solid Neoplasm × Rifampin × Clear all
NCT03486314 2022-04-18

A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors

Takeda

Phase 1 Completed
20 enrolled 18 charts

Advanced Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡